Point72 Asset Management’s Abiomed Inc ABMD Stock Holding History

Point72 Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-53,999	Closed	-$13.4M	–	1831
2022 Q2	$13.4M	Sell	53,999 -35,901	-40%	-$9.69M	0.06%	429
2022 Q1	$29.8M	Buy	+89,900	New	+$27.7M	0.12%	231
2019 Q3	–	Sell	-1,834	Closed	-$478K	–	1557
2019 Q2	$478K	Sell	1,834 -27,960	-94%	-$7.42M	﹤0.01%	848
2019 Q1	$8.51M	Buy	+29,794	New	+$9.9M	0.04%	440
2017 Q2	–	Sell	-56,700	Closed	-$7.1M	–	1048
2017 Q1	$7.1M	Sell	56,700 -35,900	-39%	-$4.16M	0.04%	464
2016 Q4	$10.4M	Buy	+92,600	New	+$10.7M	0.07%	303
2015 Q3	–	Sell	-105,000	Closed	-$6.9M	–	935
2015 Q2	$6.9M	Buy	+105,000	New	+$6.98M	0.05%	398

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Point72 Asset Management's ABMD Position: Q3 2022 in Review

Point72 Asset Management sold out of Abiomed Inc (ABMD) in Q3 2022, closing a stake of 53,999 shares — an estimated $13.4M sold.

Point72 Asset Management first reported a position in ABMD in Q2 2015 and held it in 7 quarters. The position peaked at $29.8M in Q1 2022. 517 funds tracked by Wall St. Rank hold ABMD as of Q3 2022.

Point72 Asset Management reported no remaining Abiomed Inc position as of Q3 2022 after selling out during the quarter.
Point72 Asset Management sold 53,999 Abiomed Inc shares in Q3 2022, an estimated $13.4M.
Point72 Asset Management first reported a position in Abiomed Inc in Q2 2015 and held it in 7 quarters.
Point72 Asset Management's Abiomed Inc position peaked at $29.8M in Q1 2022.
517 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2022.

Based on Point72 Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.